{
    "clinical_study": {
        "@rank": "25000", 
        "brief_summary": {
            "textblock": "Compassionate use of Stiripentol in Dravet Syndrome. This is a treatment protocol, not a\n      research study, therefore children will only be monitored on a clinical basis for seizure\n      improvement predominantly by parent and caregiver report."
        }, 
        "brief_title": "Compassionate Use of Stiripentol in Dravet Syndrome", 
        "condition": "Dravet Syndrome", 
        "condition_browse": {
            "mesh_term": "Epilepsies, Myoclonic"
        }, 
        "detailed_description": {
            "textblock": "This is a treatment protocol for compassionate use, not a research study, therefore children\n      will only be monitored on a clinical basis for seizure improvement predominantly by parent\n      and caregiver report."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Children with genetic confirmation of Dravet syndrome (a documented sodium channel,\n        voltage-gated, type I, alpha subunit (SCN1A) mutation) or clinical confirmation of Dravet\n        syndrome by two pediatric neurologist will be considered to have Dravet syndrome.  In\n        order to enter the treatment protocol there will be documented treatment failure of at\n        least two therapeutic anticonvulsants excluding Na channel blockers.  Anticonvulsants that\n        are Na channel blockers such as carbamazepine and lamotrigine as known to provoke seizures\n        in this patient population."
            }, 
            "gender": "Both", 
            "maximum_age": "21 Years", 
            "minimum_age": "1 Year"
        }, 
        "firstreceived_date": "April 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01835314", 
            "org_study_id": "12-0315"
        }, 
        "intervention": {
            "description": "Stiripentol 5-50mg/kg/d divided twice or three times a day by mouth", 
            "intervention_name": "Stiripentol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Stiripentol"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "December 16, 2013", 
        "location": {
            "contact": {
                "email": "kelly.knupp@childrenscolorado.org", 
                "last_name": "Kelly Knupp, MD", 
                "phone": "720-777-6895"
            }, 
            "contact_backup": {
                "email": "alicia.camuto@childrenscolorado.org", 
                "last_name": "Alicia Camuto, BA", 
                "phone": "720-777-5514"
            }, 
            "facility": {
                "address": {
                    "city": "Aurora", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80045"
                }, 
                "name": "Children's Hospital Colorado"
            }, 
            "investigator": {
                "last_name": "Kelly Knupp, MD", 
                "role": "Principal Investigator"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Compassionate Use of Stiripentol in Dravet Syndrome", 
        "overall_contact": {
            "email": "kelly.knupp@childrenscolorado.org", 
            "last_name": "Kelly Knupp, MD", 
            "phone": "720-777-6895"
        }, 
        "overall_contact_backup": {
            "email": "alicia.camuto@childrenscolorado.org", 
            "last_name": "Alicia M Camuto, BA", 
            "phone": "720-777-5514"
        }, 
        "overall_official": {
            "affiliation": "University of Colorado/Children's Hospital Colorado", 
            "last_name": "Kelly Knupp, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Available", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration", 
                "United States: Federal Government"
            ]
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01835314"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Colorado, Denver", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Colorado, Denver", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Expanded Access", 
        "verification_date": "December 2013"
    }
}